Discontinued — last reported Q4 '25
Exxon Mobil Business Sale Proceeds increased by 633.8% to $1.02B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 68.4%, from $3.23B to $1.02B. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows relatively stable performance with a -0.1% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $250.00M | $18.00M | $2.60B | $293.00M | $939.00M | $2.68B | $1.33B | $854.00M | $1.29B | $917.00M | $1.02B | $703.00M | $926.00M | $127.00M | $3.23B | $1.82B | $176.00M | $139.00M | $1.02B |
| QoQ Change | — | -92.8% | >999% | -88.7% | +220.5% | +185.6% | -50.3% | -35.9% | +50.7% | -28.7% | +11.2% | -31.1% | +31.7% | -86.3% | >999% | -43.6% | -90.3% | -21.0% | +633.8% |
| YoY Change | — | — | — | — | +275.6% | >999% | -48.8% | +191.5% | +37.1% | -65.8% | -23.5% | -17.7% | -28.0% | -86.2% | +216.8% | +159.3% | -81.0% | +9.4% | -68.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.